The results showed that supplementation with ILA, IAA, Arg, or butyrate significantly inhibited tumor growth and reduced tumor volume, size, and weight compared to the vehicle group in the CT26 syngeneic mouse model (Fig. 7B-D). Here, TNFRSF9 is linked to neoplasm.